Michael J. Fox Foundation significantly expands Parkinson’s study 15-Dec-2021 By Jenni Spinner The Parkinson’s Progression Markers Initiative, built using Evidation Health’s research platform, aims to triple enrollment and recruit online participants.
Positive outcomes for Lenti-D trial, bluebird chasing regulatory approvals 03-Sep-2020 By Jane Byrne Bluebird bio has reported end points were met in a clinical trial involving its candidate ALD cell therapy, branded as Lenti-D.